Renal outcomes in the ONTARGET study – Authors' reply
暂无分享,去创建一个
S. Yusuf | R. Schmieder | K. Teo | J. Mann
[1] R. Kunz,et al. The COOPERATE trial: a letter of concern , 2008, The Lancet.
[2] G. Remuzzi,et al. Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes. , 2006, The Journal of clinical investigation.
[3] G. Remuzzi,et al. Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial , 2005, The Lancet.
[4] J. Mustonen,et al. Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy. , 2004, The New England journal of medicine.
[5] Keith C. Norris,et al. Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial. , 2001, JAMA.